Crotamiton

Crotamiton (CAS No.: 483-63-6) is a synthetic ectoparasiticide and antipruritic agent widely utilized in dermatological research and drug discovery contexts for its dual activity in alleviating itch and eradicating scabies-causing parasites. Functionally, it has been identified as an inhibitor of transient receptor potential vanilloid 4 (TRPV4) channels, suppressing TRPV4-mediated currents in a calcium-dependent manner and modulating pruritus-associated signaling pathways. In vitro and cellular studies demonstrate that crotamiton inhibits histamine- and chloroquine-induced calcium influx through pathways involving H1 receptor/TRPV1 and MRGPRA3/TRPA1 signaling, as well as attenuating calcium responses in primary dorsal root ganglion neurons, indicating a broader regulatory role in sensory neuron activation. These activities are typically observed in the low to mid micromolar range, supporting its utility as a pharmacological tool for investigating itch mechanisms and neuroimmune interactions. In vivo, crotamiton reduces pruritus-related behaviors in murine models induced by TRPV4 agonists and other pruritogens such as histamine, serotonin, and PAR2 agonists, highlighting its relevance for translational itch research. Commonly formulated as a topical preparation due to its physicochemical properties as a colorless to slightly yellowish oil miscible with organic solvents, crotamiton is applied in experimental settings to study antipruritic efficacy, sensory signaling modulation, and antiparasitic activity, with dosing regimens adapted to specific model systems and research objectives.